Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity

Por Hartford, Christine M, Dolan, M Eileen
Publicado em 2007

The Impact of Pharmacogenomics on the Management of Cardiac Disease

Por Pereira, NL, Weinshilboum, RM
Publicado em 2011

Delivering systems pharmacogenomics towards precision medicine through mathematics

Por Wang, Yaqun, Wang, Ningtao, Wang, Jianxin, Wang, Zhong, Wu, Rongling
Publicado em 2013

Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative Project

Por Gaedigk, Andrea, Turner, Amy, Everts, Robin E., Scott, Stuart A., Aggarwal, Praful, Broeckel, Ulrich, McMillin, Gwendolyn A., Melis, Roberta, Boone, Erin C., Pratt, Victoria M., Kalman, Lisa V.
Publicado no J Mol Diagn (2019)

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms

Por Reynolds, Gavin P, McGowan, Olga O, Dalton, Caroline F
Publicado em 2014

The genetics of human drug response

Por Goldstein, David B
Publicado em 2005

Personalized pharmacotherapy for Type 2 diabetes mellitus

Por Sathananthan, Airani, Vella, Adrian
Publicado em 2009

Mapping of hepatic expression quantitative trait loci (eQTLs) in a Han Chinese population

Por Wang, Xiaoliang, Tang, Huamei, Teng, Mujian, Li, Zhiqiang, Li, Jianguo, Fan, Junwei, Zhong, Lin, Sun, Xing, Xu, Junming, Chen, Guoqing, Chen, Dawei, Wang, Zhaowen, Xing, Tonghai, Zhang, Jinyan, Huang, Li, Wang, Shuyun, Peng, Xiao, Qin, Shengying, Shi, Yongyong, Peng, Zhihai
Publicado em 2014

IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti–IL-4 receptor α antagonist

Por Slager, Rebecca E., Otulana, Babatunde A., Hawkins, Gregory A., Yen, Yu Ping, Peters, Stephen P., Wenzel, Sally E., Meyers, Deborah A., Bleecker, Eugene R.
Publicado em 2012

Precision Medicine in Lymphoma by Innovative Instrumental Platforms

Por Di Paolo, Antonello, Arrigoni, Elena, Luci, Giacomo, Cucchiara, Federico, Danesi, Romano, Galimberti, Sara
Publicado no Front Oncol (2019)

Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here?

Por Urban, Thomas J., Goldstein, David B., Watkins, Paul B.
Publicado em 2012

Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests

Por Thauvin-Robinet, Christel, Thevenon, Julien, Nambot, Sophie, Delanne, Julian, Kuentz, Paul, Bruel, Ange-Line, Chassagne, Aline, Cretin, Elodie, Pelissier, Aurore, Peyron, Chritine, Gautier, Elodie, Lehalle, Daphné, Jean-Marçais, Nolwenn, Callier, Patrick, Mosca-Boidron, Anne-Laure, Vitobello, Antonio, Sorlin, Arthur, Tran Mau-Them, Frédéric, Philippe, Christophe, Vabres, Pierre, Demougeot, Laurent, Poé, Charlotte, Jouan, Thibaud, Chevarin, Martin, Lefebvre, Mathilde, Bardou, Marc, Tisserant, Emilie, Luu, Maxime, Binquet, Christine, Deleuze, Jean-François, Verstuyft, Céline, Duffourd, Yannis, Faivre, Laurence
Publicado no Eur J Hum Genet (2019)

The genetics of type 2 diabetes: what have we learned from GWAS?

Por Billings, Liana K., Florez, Jose C.
Publicado em 2010

Pharmacogenomics: Challenges and Opportunities

Por Roden, Dan M., Altman, Russ B., Benowitz, Neal L., Flockhart, David A., Giacomini, Kathleen M., Johnson, Julie A., Krauss, Ronald M., McLeod, Howard L., Ratain, Mark J., Relling, Mary V., Ring, Huijun Z., Shuldiner, Alan R., Weinshilboum, Richard M., Weiss, Scott T.
Publicado no Ann Intern Med (2006)

Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses

Por Trompet, Stella, de Craen, Anton JM, Postmus, Iris, Ford, Ian, Sattar, Naveed, Caslake, Muriel, Stott, David J, Buckley, Brendan M, Sacks, Frank, Devlin, James J, Slagboom, P Eline, Westendorp, Rudi GJ, Jukema, J Wouter
Publicado em 2011

Pharmacogenomics of Breast Cancer Therapy: An Update

Por Westbrook, Kelly, Stearns, Vered
Publicado em 2013

Pharmacogenomics Discovery and Implementation in GWAS Era

Por Ni, Xiuqin, Zhang, Wei, Huang, R. Stephanie
Publicado em 2012

Creating and evaluating genetic tests predictive of drug response

Por Weiss, Scott T., McLeod, Howard L., Flockhart, David A., Dolan, M. Eileen, Benowitz, Neal L., Johnson, Julie A., Ratain, Mark J., Giacomini, Kathleen M.
Publicado em 2008

Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation

Por Kim, Kyungpil, Bolotin, Eugene, Theusch, Elizabeth, Huang, Haiyan, Medina, Marisa W, Krauss, Ronald M
Publicado em 2014

Genetics, Ancestry, and Hypertension: Implications for Targeted Antihypertensive Therapies

Por Franceschini, Nora, Chasman, Daniel I., Cooper-DeHoff, Rhonda M., Arnett, Donna K.
Publicado no Curr Hypertens Rep (2014)